Non-regulatory
Sedana Medical AB (“Sedana Medical” or “the Company”) is recruiting Thor Sundsvik as its Nordic Sales Manager and is thus established in the Nordic region with its own sales organization. Thor Sundsvik joins from Linde Healthcare and will take up his…
Regulatory
Strong sales growth and initiated registration study for Europe
Regulatory
Pareto Securities has notified Sedana Medical AB (publ) (”Sedana Medical” or the ”Company”), that the overallotment option has been exercised in full.
Regulatory
Sedana Medical AB’s (“Sedana Medical”) product AnaConDa is used in South Korea and Asia for the first time. South Korea is the first country in Asia to approve, launch and use AnaConDa for inhalation sedation of mechanically ventilated patients in in…
Regulatory
Sedana Medical AB (publ) (Sedana Medical) has reached an agreement with the American medical device corporation Teleflex Medical Incorporation (Teleflex) to finally make a settlement of current royalty agreement for the AnaConDa products.
Non-regulatory
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLI…
Non-regulatory
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLI…
Non-regulatory
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONGKONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLIC…
Non-regulatory
An eventful quarter with positive sales development
Non-regulatory
An eventful year and a historic profit
Non-regulatory
Sedana Medical AB (publ) ("Sedana Medical" or "the Company") is launching AnaConDa-S, a new innovation and an enhancement of its predecessor AnaConDa, in which the ‘dead volume’ has been halved from 100 ml to 50 ml. Halving the dead volume increases…
Non-regulatory
Sedana Medical AB’s (publ) (“Sedana Medical” or " the Company") product AnaConDa is approved by K-FDA in South Korea. South Korea is the first country in Asia to approve AnaConDa. The product will be launched in cooperation with the distributor DaeSe…
Non-regulatory
The Board of Directors of Sedana Medical AB (publ) ("Sedana Medical" or "the Company") has appointed Christer Ahlberg as new CEO for the Company and the group. Christer Ahlberg succeeds Mike Ryan, who will focus on board management inside and outside…